Tm Bio Shareholders to Vote on Luminex Buy on Feb. 23 | GenomeWeb
NEW YORK (GenomeWeb News) — Tm Bioscience shareholder will vote on Feb. 23 to decide whether Luminex will acquire the company, Tm said today.
 
Luminex said on Dec. 15 it had agreed in principle to purchase Tm in a stock-for-stock deal in which Luminex would buy a 41.5 percent stake in Tm. Luminex said it plans to deliver Tm’s kits and reagents to wider markets through its business channels.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.